MMP9 and cancer: Other studies show that PGV-1 inhibits matrix metalloproteinase 9 (MMP9) expression and cancer cell migration on 4T1 cells, indicating that PGV-1 can also be developed as an inhibitor of TNBC metastasis (Meiyanto et al., 2020).